Literature DB >> 22094468

Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic.

Charlotte A Dodson1, Richard Bayliss.   

Abstract

Protein kinases are activated by phosphorylation and by the binding of activator proteins. The interplay of these two factors is incompletely understood. We applied energetic analysis to this question and characterized the activation process of the serine/threonine kinase Aurora-A by phosphorylation and by its protein partner, targeting protein for Xenopus kinesin-like protein 2 (TPX2). We discovered that these two activators act synergistically and without a predefined order: each can individually increase the activity of Aurora-A, and the effect of both bound together is the exact sum of their individual contributions to catalysis. Unexpectedly, the unphosphorylated enzyme has catalytic activity that is increased 15-fold by the binding of TPX2 alone. The energetic contribution of phosphorylation to catalysis is 2-fold greater than that of TPX2 binding, which is independent of the phosphorylation state of the enzyme. Based on this analysis, we propose a revised, fluid model of Aurora-A activation in which the first step is a reduction in the mobility of the activation loop by either TPX2 binding or phosphorylation. Furthermore, our results suggest that unphosphorylated Aurora-A bound to the mitotic spindle by TPX2 is catalytically active and that the phosphorylation state of Aurora-A is an inaccurate surrogate for its activity. Extending this form of analysis will allow us to compare quantitatively the effects of the whole network of kinase-activating partners. Comparison with other kinases showed that kinetic characterization detects those kinases whose activation loops undergo a rearrangement upon phosphorylation and thus whose unphosphorylated state offers a distinct target for the development of Type II inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094468      PMCID: PMC3256853          DOI: 10.1074/jbc.M111.312090

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Kinetic basis for activation of CDK2/cyclin A by phosphorylation.

Authors:  J C Hagopian; M P Kirtley; L M Stevenson; R M Gergis; A A Russo; N P Pavletich; S M Parsons; J Lew
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 2.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

3.  Binding of TPX2 to Aurora A alters substrate and inhibitor interactions.

Authors:  Kelly Anderson; Jingsong Yang; Kristin Koretke; Kelvin Nurse; Amy Calamari; Robert B Kirkpatrick; Denis Patrick; Domingos Silva; Peter J Tummino; Robert A Copeland; Zhihong Lai
Journal:  Biochemistry       Date:  2007-08-18       Impact factor: 3.162

Review 4.  Discovery and development of aurora kinase inhibitors as anticancer agents.

Authors:  John R Pollard; Michael Mortimore
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

5.  A kinase-independent role for Aurora A in the assembly of mitotic spindle microtubules in Caenorhabditis elegans embryos.

Authors:  Mika Toya; Masahiro Terasawa; Kayo Nagata; Yumi Iida; Asako Sugimoto
Journal:  Nat Cell Biol       Date:  2011-05-15       Impact factor: 28.824

6.  Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.

Authors:  Dominic A Sloane; Michael Z Trikic; Matthew L H Chu; Maria B A C Lamers; Clive S Mason; Ilka Mueller; Wendy J Savory; David H Williams; Patrick A Eyers
Journal:  ACS Chem Biol       Date:  2010-06-18       Impact factor: 5.100

7.  Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design.

Authors:  Charlotte A Dodson; Magda Kosmopoulou; Mark W Richards; Butrus Atrash; Vassilios Bavetsias; Julian Blagg; Richard Bayliss
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

8.  Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2.

Authors:  Kang Zeng; Ricardo Nunes Bastos; Francis A Barr; Ulrike Gruneberg
Journal:  J Cell Biol       Date:  2010-12-27       Impact factor: 10.539

9.  Discovery and exploitation of inhibitor-resistant aurora and polo kinase mutants for the analysis of mitotic networks.

Authors:  Paul J Scutt; Matthew L H Chu; Dominic A Sloane; Mike Cherry; Colin R Bignell; David H Williams; Patrick A Eyers
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

10.  VX-680 inhibits Aurora A and Aurora B kinase activity in human cells.

Authors:  Rebecca K Tyler; Natalia Shpiro; Rodolfo Marquez; Patrick A Eyers
Journal:  Cell Cycle       Date:  2007-08-27       Impact factor: 4.534

View more
  46 in total

Review 1.  Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.

Authors:  Giulia Bertolin; Marc Tramier
Journal:  Cell Mol Life Sci       Date:  2019-09-27       Impact factor: 9.261

2.  IK-guided PP2A suppresses Aurora B activity in the interphase of tumor cells.

Authors:  Sunyi Lee; Ae Lee Jeong; Jeong Su Park; Sora Han; Chang-Young Jang; Keun Il Kim; Yonghwan Kim; Jong Hoon Park; Jong-Seok Lim; Myung Sok Lee; Young Yang
Journal:  Cell Mol Life Sci       Date:  2016-02-23       Impact factor: 9.261

Review 3.  Issues in interpreting the in vivo activity of Aurora-A.

Authors:  Elena Shagisultanova; Roland L Dunbrack; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2014-11-11       Impact factor: 6.902

4.  A water-mediated allosteric network governs activation of Aurora kinase A.

Authors:  Soreen Cyphers; Emily F Ruff; Julie M Behr; John D Chodera; Nicholas M Levinson
Journal:  Nat Chem Biol       Date:  2017-02-06       Impact factor: 15.040

5.  Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.

Authors:  Su-Yeon Lee; Eun-Young Kim; Kyeoung-Hwa Kim; Kyung-Ah Lee
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

6.  The structure of C290A:C393A Aurora A provides structural insights into kinase regulation.

Authors:  Selena G Burgess; Richard Bayliss
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-02-19       Impact factor: 1.056

7.  Haspin kinase regulates microtubule-organizing center clustering and stability through Aurora kinase C in mouse oocytes.

Authors:  Ahmed Z Balboula; Alexandra L Nguyen; Amanda S Gentilello; Suzanne M Quartuccio; David Drutovic; Petr Solc; Karen Schindler
Journal:  J Cell Sci       Date:  2016-08-25       Impact factor: 5.285

8.  Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2.

Authors:  Helen Chen; Pooja Mohan; Jihong Jiang; Oksana Nemirovsky; Daniel He; Markus C Fleisch; Dieter Niederacher; Linda M Pilarski; C James Lim; Christopher A Maxwell
Journal:  Cell Cycle       Date:  2014-05-29       Impact factor: 4.534

Review 9.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

10.  Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool.

Authors:  Richard Wang; Camilla Ascanelli; Ahmed Abdelbaki; Alex Fung; Tim Rasmusson; Iacovos Michaelides; Karen Roberts; Catherine Lindon
Journal:  Commun Biol       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.